Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aggrenox
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulant, treatment, combined
aspirin
aspirin, dose of
aspirin, failure of
blacks
cerebral atherosclerosis
cerebral atherosclerosis, medical management
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prevention of
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
clopidogrel
color desaturation
complications
controversies in neurology
coronary artery disease
cost effectiveness
dementia
diabetes mellitus
dipyridamole
efficacy
endovascular therapy
ESPRIT
fibrinolytic agents
fibrinolytic agents, complications
headache
headache, drug induced
hemorrhagic diathesis
hypertension
intellectual deterioration
intracerebral hemorrhage
intracranial hemorrhage
MATCH trial
migraine
multimodal neuroimaging
old age, neurology of
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, selection
practice guidelines
prevention of neurologic disorders
PROFESS trial
race
review article
risk factors
risk factors, modification
safety
stent, coronary artery
ticagrelor
ticlopidine
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
transluminal angioplasty, intracranial
treatment of neurologic disorder
Showing articles 0 to 16 of 16

Antiplatelet Treatment to Prevent Early Recurrent Stroke
NEJM 383:276-278, Rothwell, P.M., 2020

Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014

Dual or Mono Antiplatelet Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack
Stroke 43:1058-1066, Geeganage,C.M.,et al, 2012

Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset
Stroke 41:288-294, Diedler,J.,et al, 2010

Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke: PRoFESS Subgroup Analysis
Stroke 41:732-738, Bath,P.M.W., et al, 2010

Aspirin and Extended-Release Dipyridamole Versus Clopidogrel for Recurrent Stroke
NEJM 359:1238-1251,1287, Sacco,R.L.,et al, 2008

Dipyridamole Plus Aspirin Versus Aspirin Alone in Secondary Prevention After TIA or Stroke: A Meta-Analysis by Risk
JNNP 79:12181-1223, Halkes,P.H.A.,et al, 2008

Results of the Management of Atherothrombosis With Clopidogrel in High-Risk Patients Trial
Arch Neurol 63:20-24, Fisher,M., 2006

Aspirin Plus Dipyridamole Versus Aspirin Alone After Cerebral Ischaemia of Arterial Origin (ESPRIT): Randomised Controlled Trial.
Lancet 367:1665-1673,1638, The ESPRIT Study Group, 2006

Efficacy of Aspirin Plus Extended-Release Dipyridamole in Preventing Recurrent Stroke in High-Risk Populations
Arch Neurol 62:403-408, Sacco, R.L., et al, 2005

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Combination Therapy With Clopidogrel and Aspirin
Stroke 32:2948-2949, Albers,G.W. &Amerenco,P., 2001

AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000

Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000

Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000

Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999



Showing articles 0 to 16 of 16